Mankind Pharma: Market not much enthused by Mankind’s BSV buy
Mumbai: It took a global private equity player to unite two home-bred Indian pharma companies for a deal. India’s fourth largest pharma company, Mankind Pharma, is set to acquire 100% stake in Bharat Serums & Vaccines (BSV) from global PE firm Advent International at ₹13,600 crore. After initially cheering the deal, the stock market gave … Read more
